Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Inward rectifier potassium channels are important in many body functions and diseases, and could be potential drug targets.

Early changes in brain chemicals affect how a drug reduces alcohol intake in rats.

Mesotherapy might be a useful addition to dental surgery to reduce drug use and side effects, but more research is needed.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Minoxidil is less effective on eyebrows and eyelashes than scalp hair because these areas have lower enzyme activity needed to activate the drug.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Hydrogels are promising for treating complex diseases due to their adaptability and potential in drug delivery and tissue repair.

Different substances can affect how well the skin absorbs minoxidil, a hair loss drug. Caprylic acid helps the skin absorb it the best, followed by propylene glycol and water.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

Nanoparticles improve minoxidil skin permeation, but more research needed for effective hair growth.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

Finasteride may affect PNMT, causing side effects.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Minoxidil's absorption is too variable for it to be a reliable reference drug.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

Certain factors can start hair growth in adult skin by making cells communicate and form new hair follicles.

Minoxidil is mostly safe, but high doses can cause electrolyte imbalances and heart issues in dogs.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Finasteride remains stable for two years with proper storage.

Minoxidil boosts hair growth by increasing blood flow and nutrients to hair follicles.

Spironolactone may help reduce hair loss in androgenic alopecia.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Finasteride affects young male rats' brain function and behavior negatively.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Finasteride may cause kidney damage.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

Finasteride slightly improves prostate symptoms but has minimal difference from placebo.